TY - JOUR T1 - Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection JF - medRxiv DO - 10.1101/2020.07.29.20164293 SP - 2020.07.29.20164293 AU - Liam Townsend AU - Adam H. Dyer AU - Karen Jones AU - Jean Dunne AU - Rachel Kiersey AU - Fiona Gaffney AU - Laura O’Connor AU - Aoife Mooney AU - Deirdre Leavy AU - Katie Ridge AU - Catherine King AU - Fionnuala Cox AU - Kate O’Brien AU - Joanne Dowds AU - Jamie A Sugrue AU - David Hopkins AU - Patricia Byrne AU - Tara Kingston AU - Cliona Ni Cheallaigh AU - Parthiban Nadarajan AU - Anne Marie McLaughlin AU - Nollaig M Bourke AU - Colm Bergin AU - Cliona O’Farrelly AU - Ciaran Bannan AU - Niall Conlon Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/30/2020.07.29.20164293.abstract N2 - Fatigue is a common symptom in those presenting with symptomatic COVID-19 infection. However, it is unknown if COVID-19 results in persistent fatigue in those recovered from acute infection. We examined the prevalence of fatigue in individuals recovered from the acute phase of COVID-19 illness using the Chalder Fatigue Score (CFQ-11). We further examined potential predictors of fatigue following COVID-19 infection, evaluating indicators of COVID-19 severity, markers of peripheral immune activation and circulating pro-inflammatory cytokines. Of 128 participants (49.5 ± 15 years; 54% female), more than half reported persistent fatigue (52.3%; 45/128) at 10 weeks (median) after initial COVID-19 symptoms. There was no association between COVID-19 severity (need for inpatient admission, supplemental oxygen or critical care) and fatigue following COVID-19. Additionally, there was no association between routine laboratory markers of inflammation and cell turnover (leukocyte, neutrophil or lymphocyte counts, neutrophil-to-lymphocyte ratio, lactate dehydrogenase, C-reactive protein) or pro-inflammatory molecules (IL-6 or sCD25) and fatigue post COVID-19. Female gender and those with a pre-existing diagnosis of depression/anxiety were over-represented in those with fatigue. Our findings demonstrate a significant burden of post-viral fatigue in individuals with previous SARS-CoV-2 infection after the acute phase of COVID-19 illness. This study highlights the importance of assessing those recovering from COVID-19 for symptoms of severe fatigue, irrespective of severity of initial illness, and may identify a group worthy of further study and early intervention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was performed within the Irish Clinical Academic Training (ICAT) Programme, supported by the Wellcome Trust and the Health Research Board (Grant Number 203930/B/16/Z), the Health Service Executive, National Doctors Training and Planning and the Health and Social Care, Research and Development Division, Northern Ireland.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the current study was obtained from the Tallaght University Hospital (TUH)/St James Hospital (SJH) Joint Research Ethics Committee, reference REC 2020-04 (01).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is contained within the manuscript ER -